Wall Street futures rise as Mideast tensions ease, healthcare merger talk weighs

3 min read
Wall Street futures rise as Mideast tensions ease, healthcare merger talk weighs
PrimeXBT Editorial Team
Reviewed by PrimeXBT

Topics in article

US stock index futures rose on Monday as easing Middle East tensions pulled crude prices lower. Traders also weighed a potential Bristol Myers Squibb-AstraZeneca merger and a busy week of earnings and jobs data ahead.

US stock index futures edged higher on Monday as signs of de-escalating tensions in the Middle East weighed on crude oil prices, while investors prepared for another week packed with earnings and economic data. At 5:29 a.m. ET, Dow E-minis were up 329 points, or 0.63%, and S&P 500 E-minis rose 36.75 points, or 0.49%; Nasdaq 100 E-minis added 151 points, or 0.53%.

Oil slides as Iran talks continue

President Donald Trump said talks with Iran to reopen the Strait of Hormuz would happen later in the day, though he declined to set a deadline for an agreement. Brent Crude prices fell 5.7% to $83.77 a barrel. Separately, the two-year Treasury note yield dipped four basis points to 4.291%, reflecting short-term interest rate expectations. Higher energy costs since the start of the conflict have fueled uncertainty over the toll on the global economy.

Healthcare stocks swing on merger report

A report said Bristol Myers Squibb and AstraZeneca held preliminary merger talks that could form one of the world's biggest drugmakers, worth nearly $400 billion. Bristol Myers Squibb shares rose 8% in premarket trading, while AstraZeneca slid 6%.

Fed meeting frequency and AI earnings ahead

The Federal Reserve's Kevin Warsh raised the idea of reducing the number of regularly scheduled rate-setting meetings, a report said, in line with his plan to reduce Fed guidance on rates. Traders are pricing in a 64% chance the central bank would increase interest rates in September, the CME Group's FedWatch Tool showed.

SpaceX reports its first quarterly results since going public on Tuesday, with scrutiny on its AI spending and Starlink profits; its shares, trading below their $135 offering price for nearly three weeks, inched up 0.3%. Palantir rose 2.5%, while Micron dipped 1.3% after Reuters reported Chinese rival CXMT is considering building a second memory-chip plant in Beijing.

Jobs data and earnings due this week

Healthcare, consumer and energy sectors stay in focus, with earnings from Eli Lilly, McDonald's and Occidental Petroleum due this week. Official non-farm payrolls figures are due Friday, and a business activity survey later Monday will offer a clearer picture of the manufacturing sector's health in July. Traders are also watching U.S.-Japan intervention in currency markets to halt the yen's slide.

Sources: Economy News, Reuters

Trading involves risk.

Most traded markets

XAU / USD
-0.9% 4,127.61
BRENT
+1.35% 73.620
BTC / USD
+0.7% 63,151.2
EUR / USD
-0.12% 1.14269
USTEC
-0.91% 29,428.7
XAU / USD.24
-0.9% 4,127.61
View all markets

Author

PrimeXBT
Our Editorial Team consists of leading experts with a proven record in the fields of trading, cryptocurrencies, blockchain and finance. We thoroughly research the sources of information in order to provide readers with quality content that serves edu...
Read author’s articles
Alert Triangle Risk Disclaimer
Disclaimer: Some past publications may be outdated. We recommend following our news to stay up to date with the latest information. For any questions, feel free to contact our support team via the chat below.
The content provided here is for informational purposes only. It is not intended as personal investment advice and does not constitute a solicitation or invitation to engage in any financial transactions, investments, or related activities. Past performance is not a reliable indicator of future results.
The financial products offered by the Company are complex and come with a high risk of losing money rapidly due to leverage. These products may not be suitable for all investors. Before engaging, you should consider whether you understand how these leveraged products work and whether you can afford the high risk of losing your money.
The Company does not accept clients from the Restricted Jurisdictions as indicated in our website/ T&C. Some services or products may not be available in your jurisdiction.
The applicable legal entity and its respective products and services depend on the client’s country of residence and the entity with which the client has established a contractual relationship during registration.

Today in markets

Browse Indices News

Register Now

Trading involves risk

Get started in minutes

Our clients love how fast and simple our sign-up is. It takes just a few minutes to get started!

Get Started Get Started
Get started in minutes

Need Help?

Risk Warning:
Trading in leveraged products carries a high level of risk and may not be suitable for all investors.